Katharine Fernandez
YOU?
Author Swipe
View article: Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer
Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer Open
BACKGROUNDCisplatin is often the cytotoxic drug of choice for chemoradiation therapy (CRT) for head and neck squamous cell carcinoma (HNSCC), but it can lead to irreversible hearing loss. There may be similar oncologic outcomes but differe…
View article: Effects of Cholesterol Modulation on Cisplatin-Induced Hearing Loss
Effects of Cholesterol Modulation on Cisplatin-Induced Hearing Loss Open
Cisplatin is a widely used and effective anticancer drug. However, it causes permanent sensorineural hearing loss in over 50% of treated patients. There are no FDA-approved therapies to prevent cisplatin-induced hearing loss (CIHL) in adul…
View article: Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma
Effects of neoadjuvant immunotherapy on hearing in patients with head and neck squamous cell carcinoma Open
View article: The Effects of Metformin on Cisplatin‐Induced Ototoxicity in Diabetic Patients
The Effects of Metformin on Cisplatin‐Induced Ototoxicity in Diabetic Patients Open
Objective Ototoxicity is an important side effect of cisplatin. Recent animal and in vitro studies suggest metformin may protect hearing, though human studies are lacking. We report the first retrospective clinical study exploring the effe…
View article: Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity
Macrophage depletion protects against cisplatin-induced ototoxicity and nephrotoxicity Open
Cisplatin is a widely used anticancer drug with notable side effects including ototoxicity and nephrotoxicity. Macrophages, the major resident immune cells in the cochlea and kidney, are important drivers of both inflammatory and tissue re…
View article: Large-scale annotated dataset for cochlear hair cell detection and classification
Large-scale annotated dataset for cochlear hair cell detection and classification Open
View article: Large-scale annotated dataset for cochlear hair cell detection and classification
Large-scale annotated dataset for cochlear hair cell detection and classification Open
Our sense of hearing is mediated by cochlear hair cells, of which there are two types organized in one row of inner hair cells and three rows of outer hair cells. Each cochlea contains 5 - 15 thousand terminally differentiated hair cells, …
View article: Large-scale annotated dataset for cochlear hair cell detection and classification
Large-scale annotated dataset for cochlear hair cell detection and classification Open
Our sense of hearing is mediated by cochlear hair cells, of which there are two types organized in one row of inner hair cells and three rows of outer hair cells. Each cochlea contains 5 - 15 thousand terminally differentiated hair cells, …
View article: Macrophage Depletion Protects Against Cisplatin-Induced Ototoxicity and Nephrotoxicity
Macrophage Depletion Protects Against Cisplatin-Induced Ototoxicity and Nephrotoxicity Open
Cisplatin is a widely used and highly effective anti-cancer drug with significant side effects including ototoxicity and nephrotoxicity. Macrophages, the major resident immune cells in the cochlea and kidney, are important drivers of both …
View article: EP06.03-08 Clinical Study to Molecularly Profile Filipino Lung Adenocarcinoma
EP06.03-08 Clinical Study to Molecularly Profile Filipino Lung Adenocarcinoma Open
View article: Large-scale annotated dataset for cochlear hair cell detection and classification
Large-scale annotated dataset for cochlear hair cell detection and classification Open
Our sense of hearing is mediated by cochlear hair cells, of which there are two types organized in one row of inner hair cells and three rows of outer hair cells. Each cochlea contains 5 - 15 thousand terminally differentiated hair cells, …
View article: Large-scale annotated dataset for cochlear hair cell detection and classification
Large-scale annotated dataset for cochlear hair cell detection and classification Open
This is the dataset behind the Hair Cell Analysis Toolbox (HCAT)
View article: Large-scale annotated dataset for cochlear hair cell detection and classification
Large-scale annotated dataset for cochlear hair cell detection and classification Open
Our sense of hearing is mediated by cochlear hair cells, localized within the sensory epithelium called the organ of Corti. There are two types of hair cells in the cochlea, which are organized in one row of inner hair cells and three rows…
View article: Hear and Now: Ongoing Clinical Trials to Prevent Drug-Induced Hearing Loss
Hear and Now: Ongoing Clinical Trials to Prevent Drug-Induced Hearing Loss Open
Each year over half a million people experience permanent hearing loss caused by treatment with therapeutic drugs with ototoxic side effects. There is a major unmet clinical need for therapies that protect against this hearing loss without…
View article: Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness
Combined AAV-mediated gene replacement therapy improves auditory function in a mouse model of human DFNB42 deafness Open
View article: Large-scale annotated dataset for cochlear hair cell detection and classification
Large-scale annotated dataset for cochlear hair cell detection and classification Open
This is the dataset behind the Hair Cell Analysis Toolbox (HCAT)
View article: Single-Cell RNA-Seq of Cisplatin-Treated Adult Stria Vascularis Identifies Cell Type-Specific Regulatory Networks and Novel Therapeutic Gene Targets
Single-Cell RNA-Seq of Cisplatin-Treated Adult Stria Vascularis Identifies Cell Type-Specific Regulatory Networks and Novel Therapeutic Gene Targets Open
The endocochlear potential (EP) generated by the stria vascularis (SV) is necessary for hair cell mechanotransduction in the mammalian cochlea. We sought to create a model of EP dysfunction for the purposes of transcriptional analysis and …
View article: Atorvastatin is associated with reduced cisplatin-induced hearing loss
Atorvastatin is associated with reduced cisplatin-induced hearing loss Open
BACKGROUNDCisplatin is widely used to treat adult and pediatric cancers. It is the most ototoxic drug in clinical use, resulting in permanent hearing loss in approximately 50% of treated patients. There is a major need for therapies that p…
View article: Trk agonist drugs rescue noise-induced hidden hearing loss
Trk agonist drugs rescue noise-induced hidden hearing loss Open
TrkB agonist drugs are shown here to have a significant effect on the regeneration of afferent cochlear synapses after noise-induced synaptopathy. The effects were consistent with regeneration of cochlear synapses that we observed in vitro…
View article: Feasibility of Portable Audiometry for Ototoxicity Monitoring in a Radiation Oncology Clinic for Head and Neck Cancer Patients Receiving Cisplatin-Based Chemoradiotherapy
Feasibility of Portable Audiometry for Ototoxicity Monitoring in a Radiation Oncology Clinic for Head and Neck Cancer Patients Receiving Cisplatin-Based Chemoradiotherapy Open
View article: Trk Agonist Drugs Rescue Noise-Induced Hidden Hearing Loss
Trk Agonist Drugs Rescue Noise-Induced Hidden Hearing Loss Open
TrkB agonist drugs are shown here to have a significant effect on the regeneration of afferent cochlear synapses after noise-induced synaptopathy. The effects were consistent with regeneration of cochlear synapses that we observed in vitro…
View article: Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents
Ototoxicity and Platinum Uptake Following Cyclic Administration of Platinum-Based Chemotherapeutic Agents Open
View article: Stability of Early Auditory Evoked Potential Components Over Extended Test-Retest Intervals in Young Adults
Stability of Early Auditory Evoked Potential Components Over Extended Test-Retest Intervals in Young Adults Open
Objectives: Synaptic damage from noise exposures can occur even in the absence of changes in hearing sensitivity in animal models. There is an unmet clinical need for measurements sensitive to such damage to the human auditory system that …
View article: Lovastatin protects against cisplatin-induced hearing loss in mice
Lovastatin protects against cisplatin-induced hearing loss in mice Open
View article: Noise-induced Cochlear Synaptopathy with and Without Sensory Cell Loss
Noise-induced Cochlear Synaptopathy with and Without Sensory Cell Loss Open
View article: Planned Observational Study of Hearing Loss and the Effects of Statin Drugs in Head and Neck Squamous Cell Carcinoma Patients Treated With Chemoradiation
Planned Observational Study of Hearing Loss and the Effects of Statin Drugs in Head and Neck Squamous Cell Carcinoma Patients Treated With Chemoradiation Open
View article: Cisplatin is retained in the cochlea indefinitely following chemotherapy
Cisplatin is retained in the cochlea indefinitely following chemotherapy Open
View article: Aging after Noise Exposure: Acceleration of Cochlear Synaptopathy in “Recovered” Ears
Aging after Noise Exposure: Acceleration of Cochlear Synaptopathy in “Recovered” Ears Open
Cochlear synaptic loss, rather than hair cell death, is the earliest sign of damage in both noise- and age-related hearing impairment (Kujawa and Liberman, 2009; Sergeyenko et al., 2013). Here, we compare cochlear aging after two types of …